Inhibitory actions of oxyresveratrol on the PI3K/AKT signaling cascade in cervical cancer cells
Author:
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference45 articles.
1. Cervical cancer;Cohen;Lancet,2019
2. Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins;Yugawa;Rev. Med. Virol.,2009
3. Homeostasis and the importance for a balance between AKT/mTOR activity and intracellular signaling;Altomare;Curr. Med. Chem.,2012
4. The activation of Akt/PKB signaling pathway and cell survival;Song;J. Cell Mol. Med,2005
5. Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth;Gibbons;Semin. Oncol.,2009
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Oxyresveratrol Enhances the Anti-Cancer Effect of Cisplatin against Epithelial Ovarian Cancer Cells through Suppressing the Activation of Protein Kinase B (AKT);Biomolecules;2024-09-09
2. Novel Hsp90-Targeting PROTACs: Enhanced synergy with cisplatin in combination therapy of cervical cancer;European Journal of Medicinal Chemistry;2024-09
3. The Anti‐Metastatic Action of Oxyresveratrol via Suppression of Phosphoryl‐ERK/‐PKCα‐Mediated Sp1/MMP1 Signaling in Human Renal Carcinoma Cells;Environmental Toxicology;2024-08-22
4. Unearthing the Potential Therapeutic Effects of Oxyresveratrol Based on Intrinsic Links between Pharmacological Effects: Implications for the Gut–Liver–Brain Axis;Pharmaceuticals;2024-08-13
5. Small molecule inhibitors of the VEGF and tyrosine kinase for the treatment of cervical cancer;Medical Oncology;2024-07-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3